The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience G Revon-Riviere, L Ninove, V Min, A Rome, C Coze, A Verschuur, ... European journal of cancer 154, 30-34, 2021 | 53 | 2021 |
Clinical practice guideline for the prevention of oral and oropharyngeal mucositis in pediatric cancer and hematopoietic stem cell transplant patients: 2021 update P Patel, PD Robinson, C Baggott, P Gibson, G Ljungman, N Massey, ... European journal of cancer 154, 92-101, 2021 | 38 | 2021 |
High‐intensity end‐of‐life care among children, adolescents, and young adults with cancer who die in the hospital: A population‐based study from the French national hospital … G Revon‐Rivière, V Pauly, K Baumstarck, C Bernard, N André, JC Gentet, ... Cancer 125 (13), 2300-2308, 2019 | 36 | 2019 |
A randomized trial of physical activity in children and adolescents with cancer P Saultier, C Vallet, F Sotteau, Z Hamidou, JC Gentet, V Barlogis, ... Cancers 13 (1), 121, 2021 | 25 | 2021 |
Metronomic chemotherapy for children in low-and middle-income countries: Survey of current practices and opinions of pediatric oncologists G Revon-Rivière, S Banavali, L Heississen, W Gomez Garcia, ... Journal of Global Oncology 5, 1-8, 2019 | 16 | 2019 |
Metronomic maintenance with weekly vinblastine after induction with bevacizumab-irinotecan in children with low-grade glioma prevents early relapse C Roux, G Revon-Rivière, JC Gentet, A Verschuur, D Scavarda, P Saultier, ... Journal of Pediatric Hematology/Oncology 43 (5), e630-e634, 2021 | 10 | 2021 |
Translating the symptom screening in pediatrics tool (SSPedi) into French and among French-speaking children receiving cancer treatments, evaluating understandability and … V Larouche, G Revon-Rivière, D Johnston, O Adeniyi, P Giannakouros, ... BMJ open 10 (4), e035265, 2020 | 6 | 2020 |
Symptom Screening in Pediatrics Tool in children and adolescents with high-risk malignancies: a pilot study S Szepetowski, P Saultier, N Andre, V Pauly, LL Dupuis, L Sung, ... BMJ Supportive & Palliative Care 13 (e1), e70-e73, 2023 | 5 | 2023 |
Blood-Derived Liquid Biopsies Using Foundation One® Liquid CDx for Children and Adolescents with High-Risk Malignancies: A Monocentric Experience F Cahn, G Revon-Riviere, V Min, A Rome, P Filaine, A Pelletier, S Abed, ... Cancers 14 (11), 2774, 2022 | 5 | 2022 |
Ensuring access to innovative therapies for children, adolescents, and young adults across Canada: The single patient study experience G Revon-Riviere, LC Young, EA Stephenson, K Brodeur-Robb, ... Paediatrics & Child Health 28 (7), 399-403, 2023 | 3 | 2023 |
Favorable outcome of COVID-19 infection in a pediatric cancer patient receiving an anti-PD-L1/anti-CTLA-4 combination G Revon-Riviere, C Soler, T Andrianarivony, S Fily, N André Journal of Pediatric Hematology/Oncology 43 (7), e1045-e1046, 2021 | 2 | 2021 |
Patients requiring pediatric palliative care for advanced heart disease in France: a descriptive study C La Fay, P Le Moine, L Blanc, W Abou Chahla, NP Hoang, ... Archives de Pédiatrie 28 (7), 548-552, 2021 | 2 | 2021 |
First step toward high‐intensity end‐of‐life care definition in pediatric oncology: Response to bereaved parents' views on end‐of‐life care for children with cancer: Quality … G Revon‐Rivière, S Szepetowski, P Saultier, N André Cancer (0008543X) 127 (2), 2021 | 2 | 2021 |
ctDNA quantification improves estimation of outcomes in patients with high-grade osteosarcoma: a translational study from the OS2006 trial B Audinot, D Drubay, N Gaspar, A Mohr, C Cordero, P Marec-Bérard, ... Annals of Oncology, 2023 | 1 | 2023 |
BNT162b2 COVID-19 Vaccines in Children, Adolescents and Young Adults with Cancer—A 1-Year Follow-Up C Donze, V Min, L Ninove, X de Lamballerie, G Revon Rivière, ... Vaccines 11 (5), 989, 2023 | 1 | 2023 |
A sport room within the paediatric oncology ward G Revon-Rivière, P Saultier, R Andrianarivony, C Vallet, N André ecancermedicalscience 15, 2021 | 1 | 2021 |
Mortality and survival rates in children and adolescents enrolled in early phase trials with a dose-finding/dose-confirmation component: An innovative therapies for children … F Carceller, F Bautista, A Castañeda, A Surun, A Wasti, G Revon-Riviere, ... Journal of Clinical Oncology 37 (15_suppl), e21509-e21509, 2019 | 1 | 2019 |
How we approach Early Phase Clinical Trial and off-label therapy consults in Pediatric Oncology: The New Agents and Innovative Therapy (NAIT) team experience G Revon-Rivière, P Tibout, J Cabral, A Siddiqi, A Doka, D Mills, K Fung, ... EJC Paediatric Oncology, 100154, 2024 | | 2024 |
Continuous Deep Sedation Until Death of Children at the End of Life: French Physicians' Opinions CA Pisa, P Le Coz, MA Einaudi, B Tosello, M Katsogiannou, ... Journal of Palliative Medicine, 2024 | | 2024 |
Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada S Judd, G Revon‐Riviere, SA Grover, RJ Deyell, MI Vanan, VA Lewis, ... Cancer Medicine 13 (3), e7033, 2024 | | 2024 |